EC Number   |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
|---|
   3.2.1.49 | 657357 |
The 1.9 A structure of alpha-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases |
Structure |
10 |
425-434 |
2002 |
Gallus gallus |
12005440 |
| 3.2.1.49 | 709530 |
The 1.9 A structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases |
J. Mol. Biol. |
393 |
435-447 |
2009 |
Homo sapiens |
19683538 |
| 3.2.1.49 | 208667 |
The action on soluble blood group A substances of an alpha-N-acetylgalactosaminidase from Helix pomatia |
Biochemistry |
5 |
1742-1747 |
1966 |
Helix pomatia |
6006833 |
| 3.2.1.49 | 715130 |
The alpha-galactosidase type A gene aglA from Aspergillus niger encodes a fully functional alpha-N-acetylgalactosaminidase |
Glycobiology |
20 |
1410-1419 |
2010 |
Aspergillus niger |
20601723 |
| 3.2.1.49 | 208660 |
The identification of alpha-galactosidase B from human liver as an alpha-N-acetylgalactosaminidase |
Biochem. Biophys. Res. Commun. |
77 |
1411-1417 |
1977 |
Homo sapiens |
901541 |
| 3.2.1.49 | 665838 |
Three dimensional structural studies of alpha-N-acetylgalactosaminidase (alpha-NAGA) in alpha-NAGA deficiency (Kanzaki disease): different gene mutations cause peculiar structural changes in alpha-NAGAs resulting in different substrate specificities and clinical phenotypes |
J. Dermatol. Sci. |
37 |
15-20 |
2005 |
Homo sapiens |
15619430 |
| 3.2.1.49 | 655254 |
Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation |
Comp. Biochem. Physiol. A |
132 |
1-8 |
2002 |
Homo sapiens |
12062184 |
| 3.2.1.49 | 707033 |
Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease |
Am. J. Hum. Genet. |
85 |
569-580 |
2009 |
Homo sapiens |
19853240 |
